Novel genetic determinants of low-level aminoglycoside resistance in Pseudomonas aeruginosa

  • Schurek K
  • Marr A
  • Taylor P
 et al. 
  • 3


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


Pseudomonas aeruginosa strains isolated from patients with persistent lung infections and cystic fibrosis have been found to gradually develop aminoglycoside resistance over time. The aim of this study was to identify potential contributors to low-level aminoglycoside resistance, which may cause such graduated increases in resistance. The Harvard P. aeruginosa PA14 nonredundant library, consisting of approximately 5,800 mutants, was screened for twofold or greater increases in tobramycin resistance. Mutants carrying mutations in a total of 135 unique genes were identified and confirmed to have reduced susceptibility to tobramycin. Many of these genes were involved predominantly in energy metabolism; however, most of these mutants did not exhibit growth defects under the conditions tested, although some exhibited the small-colony phenotype and/or defects in growth under anaerobic conditions. Lipopolysaccharide mutants were also identified, and it was found that tobramycin had a reduced ability to permeabilize the outer membranes of these mutants. The results of this study emphasize the complexity of the interactions that tobramycin may have within the bacterial cell and introduce a large number of novel genes which may play a role in tobramycin resistance. Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • K.N. Schurek

  • A.K. Marr

  • P.K. Taylor

  • I. Wiegand

  • L. Semenec

  • B.K. Khaira

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free